We use cookies to improve your experience on our Website. We need cookies to continuously improve the services, to enable certain features and when embedding services or content of third parties, such as video player. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Show detail settings
Please find more information in our privacy statement.

There you may also change your settings later.

News

Professor Lammert Receives Scientific Award 2013 of the Klüh Foundation

The Scientific Award 2013 of the Klüh Foundation for the Promotion of Innovation in Science and Research went this year to University Professor Dr. Eckhard Lammert, director of the Institute of Metabolic Physiology at the Heinrich Heine University of Düsseldorf and research group leader at the German Diabetes Center, a partner in the DZD. The award ceremony took place on May 28, 2013 in the presence of Mayor Dirk Elbers in the City Hall of Düsseldorf, the capital of the state of North-Rhine Westphalia. The laudatory speech was held by Federal Minister of Health Daniel Bahr.

 

The minister stressed the significance of Professor Lammert’s research in light of the fact that diabetes is a widespread, progressive disease affecting six million people in Germany. It causes much human suffering and annual medical costs of 6.3 billion euros. In his speech, Bahr addressed foundation donor Josef Klüh personally, saying: "Your commitment as a citizen has my deepest respect."
Professor Lammert, who estimates the number of people with type 2 diabetes in the world to be 370 million, received the award from the Foundation for his research in the field of metabolic diseases, in particular diabetes mellitus. With the award, which is endowed with 25,000 euros, the Düsseldorf professor wants to spur drug development together with his team.

Adaptability of the vascular system
The research focus of Lammert, whose specialty is the interaction of vascular and organ function, is to elucidate why some people develop type 2 diabetes while others are spared from this disease. According to Lammert, a key difference between these people is their blood vessels. Insulin-resistant people with adaptable vascular systems do not develop type 2 diabetes as easily as insulin-resistant people with defective blood vessels.
He has also studied molecular mechanisms in order to determine how cells form blood vessels, which are essential for supplying the human body with oxygen and nutrients. In addition, he is searching systematically for substances that would reactivate and also preserve the islets of Langerhans. These islets, which are aggregates of cells in the pancreas, play a key role in the regulation of blood glucose levels via the secretion of the hormone insulin.
Within the framework of his research on insulin secretion disorders, he maintains close cooperation with the University Children’s Hospital Düsseldorf. Here research focuses on the elucidation of hyperinsulinism in children. These children have a life-threatening disease characterized by severe hypoglycemia and seizures due to a congenital defect of the islets of Langerhans in the pancreas. However, with early diagnosis and the initiation of often complex treatment regimens, they can lead a relatively normal life.
It is hoped that in several years, through the research of Professor Lammert, a drug combination with beneficial effects against diabetes can be developed that can then be tested in clinical trials.

The Klüh Foundation was founded in 1986 on the occasion of the 75th anniversary of the Klüh Group, Düsseldorf. The Foundation’s founder is Mr. Josef Klüh, sole shareholder of the Klüh Group, Düsseldorf, an international multi-service provider of facility services.